Mineralocorticoid Receptors in the Pathophysiology of Vascular Inflammation and Atherosclerosis

Atherosclerosis is a chronic inflammatory disease of the vasculature that causes significant morbidity and mortality from myocardial infarction, stroke, and peripheral vascular disease. Landmark clinical trials revealed that mineralocorticoid receptor (MR) antagonists improve outcomes in cardiovascu...

Descripción completa

Detalles Bibliográficos
Autores principales: Moss, Mary E., Jaffe, Iris Z.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4585008/
https://www.ncbi.nlm.nih.gov/pubmed/26441842
http://dx.doi.org/10.3389/fendo.2015.00153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4585008/
https://www.ncbi.nlm.nih.gov/pubmed/26441842
http://dx.doi.org/10.3389/fendo.2015.00153

Ejemplares similares